← Leaderboards
Zhen Gu
University Of California Los Angeles
$1,761,066
Attributed
$1,761,066
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2018–19$2M$1.5M$1M$500K$0
'18
'19
Funding mix
By agency
NIH$1,761,066 · 3
By mechanism
R01$1,326,322 · 2
T32$434,744 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Aleksey V Matveyenko$6,776,230
- Karol E Watson$17,471,374
- Sherin U. Devaskar$31,339,941
- Willa A. Hsueh$20,743,184
- Zhengping Yi$6,465,921
Others in their field
Other Emerging Leaders on “In Vivo”
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,216,744
- Leonard Freedmand · Leidos Biomedical Research, Inc.$66,248,714
- John Damon Chodera · Sloan-Kettering Inst Can Research$43,427,103
- Tony Moody · Duke University$34,777,314
- Alan D. Palkowitz · Indiana University Indianapolis$18,925,366
Research focus
In VivoCellsInnovationMultidisciplinaryBaseCell MembraneEffectivenessEngineeringMediatingPropertyIn VitroEncapsulatedBiotechnologyBiomaterial CompatibilityAreaBiological AvailabilityBindingAnti-Pd-L1AntibodiesCaliberC57bl/6 MouseBehaviorCancer CellBrain Injuries
Grant awards (5)
Towards Glucose Transporter-Mediated Glucose-Responsive Insulin Delivery with Fast Response$441,116
R01 · FY2019 · DK · contact PI
Platelets-Mediated Delivery of Checkpoint Inhibitors for Post-Surgical Cancer Immunotherapy$418,528
R01 · FY2019 · CA · contact PI
Biotechnology Training in Biomedical Sciences and Engineering$202,706
T32 · FY2019 · GM · contact PI
Towards Glucose Transporter-Mediated Glucose-Responsive Insulin Delivery with Fast Response$466,678
R01 · FY2018 · DK · contact PI
Biotechnology Training in Biomedical Sciences and Engineering$232,038
T32 · FY2018 · GM · contact PI